Therefore, the longer time of follow-up and recruitment of new CLL patients will allow the statistical correlation analysis regarding sinusitis, bronchitis, and pneumonia, thus requiring ATB and the ratio of anti-Gal IgA and IgM to total IgA and IgM, respectively. This evidence concerns the gene CD79A and pneumonia.